跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 217 条关于
“Xinnate”
全部
217
临床试验
171
药物
21
机构
4
资讯
21
9个月前
Xinnate Advances TCP-25 for Epidermolysis Bullosa with FDA IND Approval and First Clinical Publication
去年
FDA Grants Orphan Drug Designation to Xinnate's TCP-25 for Epidermolysis Bullosa Treatment
去年
FDA Upgrades Xinnate's TCP-25 Trial for Epidermolysis Bullosa to Registrational Status
10个月前
New Research Reveals How Innate Immunity Drives Autoimmune Disease Pathogenesis
去年
Affimed Advances in Innate Cell Engager Therapies for Cancer Treatment
去年
Innate Pharma Advances Key Pipeline Assets While Implementing Strategic Restructuring
去年
Innate Pharma Unveils Growth Strategy and Highlights Clinical Trial Progress
去年
Innate Pharma and IFLI Partner to Advance IPH6501 in Follicular Lymphoma
2年前
Innate Pharma Advances Oncology Pipeline with Lacutamab, ANKET, and ADC Programs
11个月前
Innate Pharma Advances Lacutamab Toward Accelerated Approval for Rare T-Cell Lymphomas
第 1 页,共 3 页
上一页
下一页